FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365813465> ?p ?o ?g. }

• W4365813465 endingPage "197" @default.
• W4365813465 startingPage "189" @default.
• W4365813465 abstract "Pathogenetic therapy for the treatment of cystic fibrosis (CF) has been developed that modulates the CFTR protein and restores its activity as a chloride channel. This treatment is represented by CFTR modulators for various genotypes covering 85 - 90% of patients with CF. The aim was to analyze the efficacy of two targeted drugs in patients aged 6 - 18 years with CF in clinical practice during a 6-month follow-up. Methods. The study was conducted based on the analysis of the database “CF Patient Registry of the Russian Federation” for 2021 - 2022. The study included 178 patients receiving lumacaftor/ivacaftor and 158 patients receiving elexacaftor/tezacaftor/ivacaftor. Respiratory function indicators (FEV 1 , FVC), sweat test, and anthropometric data were analyzed. Results. In the group of children treated with lumacaftor/ivacaftor, Me (Q1 - Q3) body weight (kg) increased at 6-month follow-up from 40.0 (28.9 - 48.0) to 44.9 (29.3 - 50.8), p < 0.001, and the height (cm) increased from 156.0 (140.0 - 161.0) to 158.0 (143.0 - 162.0),p < 0.001. Me (Q1 - Q3) FEV 1 improved from 63.5 (42.3 - 84.8) to 72.0 (56.9 - 82.4) %,p < 0.045. Sweat test (mmol/l) decreased Me (Q1 - Q3) from 115 (101.0 - 123.0) to 86.5 (79.0 - 103.0), p < 0.001. During therapy with elexacaftor/tezacaftor/ ivacaftor, Me (Q1 - Q3) body weight (kg) increased at 6-month follow-up from 44.4 (36.8 - 50.0) to 49.3 (44.1 - 51.9),p < 0.001, and Me (Q1 -Q3) height (cm) increased from 160.5 (152.3 - 165.1) to 163.0 (155.5 - 166.9),p < 0.001. Me (Q1 - Q3) FVC and FEV 1 improved: FVC from 78.5 (60.9 - 91.0) to 90.5 (76.8 - 106.8) %,p < 0.001, FEV 1 from 73.5 (60.5 - 82.1) to 95.0 (65.3 - 107.0) %,p < 0.001. Sweat test (mmol/l) decreased from 119 (108 - 126) to 75.5 (65.3 - 88);р < 0.001. Conclusion. Health status indicators of of children with CF aged 6 - 18 years were analyzed for 6 months of targeted therapy (lumacaftor/ivacaftor and elexacaftor/tezacaftor/ivacaftor). Positive changes were observed in weight, height, respiratory function, and sweat test." @default.
• W4365813465 created "2023-04-16" @default.
• W4365813465 creator A5016853449 @default.
• W4365813465 creator A5019816660 @default.
• W4365813465 creator A5026838699 @default.
• W4365813465 creator A5054875291 @default.
• W4365813465 creator A5056719659 @default.
• W4365813465 creator A5063221055 @default.
• W4365813465 creator A5079818795 @default.
• W4365813465 creator A5090277471 @default.
• W4365813465 date "2023-04-12" @default.
• W4365813465 modified "2023-10-12" @default.
• W4365813465 title "Efficacy of CFTR modulators in clinical practice (6-month follow-up)" @default.
• W4365813465 cites W1547235908 @default.
• W4365813465 cites W1972863042 @default.
• W4365813465 cites W2070332586 @default.
• W4365813465 cites W2071407356 @default.
• W4365813465 cites W2090943591 @default.
• W4365813465 cites W2337762305 @default.
• W4365813465 cites W2620622198 @default.
• W4365813465 cites W2952212183 @default.
• W4365813465 cites W2982296199 @default.
• W4365813465 cites W2985405196 @default.
• W4365813465 cites W3156251444 @default.
• W4365813465 cites W3165786465 @default.
• W4365813465 cites W3182318848 @default.
• W4365813465 cites W4280575857 @default.
• W4365813465 cites W4295804415 @default.
• W4365813465 doi "https://doi.org/10.18093/0869-0189-2023-33-2-189-197" @default.
• W4365813465 hasPublicationYear "2023" @default.
• W4365813465 type Work @default.
• W4365813465 citedByCount "0" @default.
• W4365813465 crossrefType "journal-article" @default.
• W4365813465 hasAuthorship W4365813465A5016853449 @default.
• W4365813465 hasAuthorship W4365813465A5019816660 @default.
• W4365813465 hasAuthorship W4365813465A5026838699 @default.
• W4365813465 hasAuthorship W4365813465A5054875291 @default.
• W4365813465 hasAuthorship W4365813465A5056719659 @default.
• W4365813465 hasAuthorship W4365813465A5063221055 @default.
• W4365813465 hasAuthorship W4365813465A5079818795 @default.
• W4365813465 hasAuthorship W4365813465A5090277471 @default.
• W4365813465 hasBestOaLocation W43658134651 @default.
• W4365813465 hasConcept C126322002 @default.
• W4365813465 hasConcept C147583825 @default.
• W4365813465 hasConcept C1862650 @default.
• W4365813465 hasConcept C2776502428 @default.
• W4365813465 hasConcept C2776938444 @default.
• W4365813465 hasConcept C2776999253 @default.
• W4365813465 hasConcept C2778428886 @default.
• W4365813465 hasConcept C2779974597 @default.
• W4365813465 hasConcept C511355011 @default.
• W4365813465 hasConcept C535046627 @default.
• W4365813465 hasConcept C544821477 @default.
• W4365813465 hasConcept C61427482 @default.
• W4365813465 hasConcept C71924100 @default.
• W4365813465 hasConcept C90924648 @default.
• W4365813465 hasConceptScore W4365813465C126322002 @default.
• W4365813465 hasConceptScore W4365813465C147583825 @default.
• W4365813465 hasConceptScore W4365813465C1862650 @default.
• W4365813465 hasConceptScore W4365813465C2776502428 @default.
• W4365813465 hasConceptScore W4365813465C2776938444 @default.
• W4365813465 hasConceptScore W4365813465C2776999253 @default.
• W4365813465 hasConceptScore W4365813465C2778428886 @default.
• W4365813465 hasConceptScore W4365813465C2779974597 @default.
• W4365813465 hasConceptScore W4365813465C511355011 @default.
• W4365813465 hasConceptScore W4365813465C535046627 @default.
• W4365813465 hasConceptScore W4365813465C544821477 @default.
• W4365813465 hasConceptScore W4365813465C61427482 @default.
• W4365813465 hasConceptScore W4365813465C71924100 @default.
• W4365813465 hasConceptScore W4365813465C90924648 @default.
• W4365813465 hasIssue "2" @default.
• W4365813465 hasLocation W43658134651 @default.
• W4365813465 hasOpenAccess W4365813465 @default.
• W4365813465 hasPrimaryLocation W43658134651 @default.
• W4365813465 hasRelatedWork W2903690054 @default.
• W4365813465 hasRelatedWork W2969990195 @default.
• W4365813465 hasRelatedWork W2991507921 @default.
• W4365813465 hasRelatedWork W3015162743 @default.
• W4365813465 hasRelatedWork W3207857801 @default.
• W4365813465 hasRelatedWork W4224094999 @default.
• W4365813465 hasRelatedWork W4224260182 @default.
• W4365813465 hasRelatedWork W4280517714 @default.
• W4365813465 hasRelatedWork W4285106745 @default.
• W4365813465 hasRelatedWork W4360614930 @default.
• W4365813465 hasVolume "33" @default.
• W4365813465 isParatext "false" @default.
• W4365813465 isRetracted "false" @default.
• W4365813465 workType "article" @default.